LIMN — Liminatus Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- $22.97m
- $23.69m
Annual cashflow statement for Liminatus Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -5.61 | -2.93 | -4.98 | -3.55 |
| Depreciation | ||||
| Non-Cash Items | 2.4 | 0.9 | 0 | — |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 3.05 | 1.16 | 1.64 | 2.1 |
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accrued Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -0.168 | -0.869 | -3.35 | -1.45 |
| Other Investing Cash Flow Items | — | 0 | -0.819 | -2.85 |
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | — | 0 | -0.819 | -2.85 |
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0 | 5.92 | -0.45 | 3.92 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.168 | 5.05 | -4.61 | -0.378 |